It includes predominantly healthy individuals with low mortality whose CD4 counts were measured at scheduled visits in contrast to other cohorts with an over-representation of ill individuals for whom CD4 count may be declining due to opportunistic illnesses or infections. The gene discussed is CD4; the disease is infection.